ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.67898
-0.06%
Brent Oil
82.415
0.53%
Bitcoin
68,515.60
0.01%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Locust Walk Acquisition Corporation (LWAC)

  7. Locust Walk Acquisition Corporation (LWAC) Noticias

LWAC

Locust Walk Acquisition (LWAC)

Locust Walk Acquisition Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:LWAC
FechaHoraFuenteTítuloSímboloCompañía
27/06/202305:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:LWACLocust Walk Acquisition Corporation
23/06/202315:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LWACLocust Walk Acquisition Corporation
08/06/202305:15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:LWACLocust Walk Acquisition Corporation
08/06/202305:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:LWACLocust Walk Acquisition Corporation
16/05/202307:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LWACLocust Walk Acquisition Corporation
12/05/202315:24Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:LWACLocust Walk Acquisition Corporation
12/05/202315:19Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:LWACLocust Walk Acquisition Corporation
12/05/202315:13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:LWACLocust Walk Acquisition Corporation
09/05/202315:23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LWACLocust Walk Acquisition Corporation
08/03/202315:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:LWACLocust Walk Acquisition Corporation
07/03/202316:26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:LWACLocust Walk Acquisition Corporation
14/02/202305:35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LWACLocust Walk Acquisition Corporation
28/09/202215:43Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:LWACLocust Walk Acquisition Corporation
11/08/202215:56Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LWACLocust Walk Acquisition Corporation
18/03/202205:05Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:LWACLocust Walk Acquisition Corporation
25/01/202215:32Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:LWACLocust Walk Acquisition Corporation
17/12/202115:32Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:LWACLocust Walk Acquisition Corporation
01/10/202116:14Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:LWACLocust Walk Acquisition Corporation
03/09/202115:01Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:LWACLocust Walk Acquisition Corporation
25/08/202118:18GlobeNewswire Inc.eFFECTOR Therapeutics Debuts as Publicly Traded Next-Generation Oncology Company Advancing Mature Pipeline with New Class of Cancer TherapiesNASDAQ:LWACLocust Walk Acquisition Corporation
24/08/202115:47GlobeNewswire Inc.Locust Walk Acquisition Corp.’s Stockholders Approve Business Combination with eFFECTOR Therapeutics to Create Next-Generation Oncology Company Developing New Class of Cancer TherapiesNASDAQ:LWACLocust Walk Acquisition Corporation
23/08/202107:58Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:LWACLocust Walk Acquisition Corporation
09/08/202116:28Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:LWACLocust Walk Acquisition Corporation
22/07/202107:00GlobeNewswire Inc.eFFECTOR Therapeutics Doses First Patient with COVID-19 in Phase 1b Clinical Trial Evaluating Zotatifin as a Host-Targeted Antiviral AgentNASDAQ:LWACLocust Walk Acquisition Corporation
16/07/202107:00GlobeNewswire Inc.eFFECTOR Therapeutics Announces Publication of Tomivosertib Preclinical Data in Cell ReportsNASDAQ:LWACLocust Walk Acquisition Corporation
03/06/202115:15GlobeNewswire Inc.Locust Walk Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report ...NASDAQ:LWACLocust Walk Acquisition Corporation
27/05/202107:00GlobeNewswire Inc.eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation ...NASDAQ:LWACLocust Walk Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:LWAC

Su Consulta Reciente

COIN
NUUST
NuCypher
USOTC
NTME
Netmed (CE)
COIN
CSTOGBP
LSE
AW07
Mort.bt 23-1 56
BIT
UIJ630
Unicredit Bank
BIBX
CHESSUSDT
Chess
LSE
AJIB
Abrdn Japan Investment
LSE
HJ08
Anz Nz 25 S
COIN
CTTUSD
LSE
13TL
Nationwde. 32
EU
TKO
Tikehau Capital
ASX
HAUHD
Housing Australia
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados